/
LH
$280.00+$0.42 (+0.15%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$22.3B
82M shares
52-week range
$241.81 – $293.72
74% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NYSE
CS
Borrow rate
0.27%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$41.18
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.33B | $11.55B | $13.98B | $13.14B | $11.86B | $12.16B | $13.01B | $13.95B |
| Cost of revenue | $8.16B | $8.30B | $9.03B | $8.14B | $8.15B | $8.80B | $9.38B | $10.22B |
| Gross profit | $3.18B | $3.25B | $4.95B | $4.99B | $3.71B | $3.36B | $3.62B | $3.73B |
| Gross margin | 28.0% | 28.1% | 35.4% | 38.0% | 31.3% | 27.7% | 27.9% | 26.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $2.0M | $0 | $0 |
| Operating income | $1.33B | $1.33B | $2.45B | $3.05B | $1.44B | $725.6M | $1.09B | $1.52B |
| EBITDA | $2.06B | $2.12B | $3.25B | $3.68B | $1.95B | $1.35B | $1.81B | $2.01B |
| Net income | $883.7M | $823.8M | $1.56B | $2.38B | $1.28B | $418.0M | $746.0M | $876.5M |
| Net margin | 7.8% | 7.1% | 11.1% | 18.1% | 10.8% | 3.4% | 5.7% | 6.3% |
| EPS (diluted) | 8.61 | 8.36 | 15.88 | 24.38 | 13.96 | 4.77 | 8.84 | 10.46 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $14.7B | $18.01 | $17.71–$18.34 | 9 |
| 2027 | $15.4B | $19.49 | $18.62–$20.00 | 12 |
| 2028 | $16.1B | $21.18 | $19.05–$23.98 | 8 |
| 2029 | $17.1B | $23.58 | $23.31–$23.88 | 6 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$390.20
Price
$280.00
Implied upside
+39%
Peer comparison
Labcorp Holdings Inc.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
www.labcorp.com- Employees
- 71,000
- IPO / List date
- Jul 7, 1988
- HQ
- BURLINGTON, NC
Held by traders on TradeandTell
No one on the platform currently holds LH.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-09-30 | 59,205 | $13.2M |
| Bridgewater Associatesas of 2026-03-31 | 11,184 | $3.0M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.03% ($2.88/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-29 | $0.7200 | 2026-06-11 |
| 2026-02-27 | $0.7200 | 2026-03-12 |
| 2025-11-26 | $0.7200 | 2025-12-11 |
| 2025-08-28 | $0.7200 | 2025-09-11 |
| 2025-05-29 | $0.7200 | 2025-06-11 |
| 2025-02-27 | $0.7200 | 2025-03-12 |
| 2024-11-26 | $0.7200 | 2024-12-13 |
| 2024-08-29 | $0.7200 | 2024-09-13 |
| 2024-05-24 | $0.7200 | 2024-06-12 |
| 2024-02-26 | $0.7200 | 2024-03-13 |
Recent trades on TradeandTell
No one on the platform has traded LH yet.
